We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$185M
AUM Growth
+$1.29M
Cap. Flow
-$2M
Cap. Flow %
-1.08%
Top 10 Hldgs %
22.96%
Holding
97
New
1
Increased
24
Reduced
29
Closed
2

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$192K
2
MOS icon
The Mosaic Company
MOS
+$114K
3
CHRW icon
C.H. Robinson
CHRW
+$91.7K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$83.4K
5
VZ icon
Verizon
VZ
+$79.2K

Top Sells

Rank Stock Value
1
HWM icon
Howmet Aerospace
HWM
+$1.88M
2
HPE icon
Hewlett Packard
HPE
+$210K
3
DE icon
Deere & Co
DE
+$175K
4
AAPL icon
Apple
AAPL
+$146K
5
CMCSA icon
Comcast
CMCSA
+$115K

Sector Composition

Rank Sector Weight
1 Industrials 16.29%
2 Technology 12.65%
3 Financials 12.53%
4 Healthcare 11.35%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
26
United Parcel Service
UPS
$96.2B
$3.17M 1.71%
28,666
+50
+0.2% +$5.34K
IVV icon
27
iShares Core S&P 500 ETF
IVV
$879B
$3.17M 1.71%
13,011
+309
+2% +$74.6K
WFC icon
28
Wells Fargo
WFC
$261B
$3.16M 1.71%
57,039
-80
-0.1% -$4.29K
FAST icon
29
Fastenal
FAST
$51.4B
$3.05M 1.65%
280,036
-80
-0% -$898
STT icon
30
State Street
STT
$50.2B
$3.03M 1.64%
33,791
-100
-0.3% -$8.32K
BNY
31
Bank of New York Mellon
BNY
$108B
$3M 1.62%
58,730
-70
-0.1% -$3.35K
GOOGL icon
32
Alphabet (Google) Class A
GOOGL
$4.3T
$2.99M 1.62%
64,240
-600
-0.9% -$28.1K
ABT icon
33
Abbott
ABT
$177B
$2.96M 1.6%
60,912
+100
+0.2% +$4.53K
CHRW icon
34
C.H. Robinson
CHRW
$24.3B
$2.91M 1.57%
42,336
+1,295
+3% +$91.7K
IEFA icon
35
iShares Core MSCI EAFE ETF
IEFA
$185B
$2.87M 1.55%
47,170
+450
+1% +$27.2K
PG icon
36
Procter & Gamble
PG
$347B
$2.87M 1.55%
32,962
+110
+0.3% +$9.7K
CVS icon
37
CVS Health
CVS
$137B
$2.83M 1.53%
35,187
+520
+1% +$41.1K
WU icon
38
Western Union
WU
$2.71B
$2.79M 1.51%
146,265
+1,420
+1% +$27.5K
BBH icon
39
VanEck Biotech ETF
BBH
$394M
$2.75M 1.49%
21,908
OMC icon
40
Omnicom Group
OMC
$23.5B
$2.66M 1.44%
32,094
+415
+1% +$34.6K
SPY icon
41
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.54M 1.37%
10,491
-18
-0.2% -$4.31K
COP icon
42
ConocoPhillips
COP
$141B
$2.41M 1.3%
54,826
+515
+0.9% +$24K
PX
43
DELISTED
Praxair Inc
PX
$2.27M 1.23%
17,120
USB icon
44
US Bancorp
USB
$98.4B
$2.25M 1.22%
43,270
+80
+0.2% +$4.12K
HYG icon
45
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.4B
$2.06M 1.12%
23,355
+530
+2% +$46.6K
VZ icon
46
Verizon
VZ
$182B
$1.93M 1.04%
43,229
+1,700
+4% +$79.2K
VB icon
47
Vanguard Small-Cap ETF
VB
$79.2B
$1.89M 1.02%
13,930
-80
-0.6% -$10.7K
HD icon
48
Home Depot
HD
$332B
$1.64M 0.89%
10,675
VTI icon
49
Vanguard Total Stock Market ETF
VTI
$657B
$1.54M 0.83%
12,380
T icon
50
AT&T
T
$153B
$1.52M 0.82%
53,214
+175
+0.3% +$5.16K

Similar funds

Boston Research & Management's Q2 2017 Portfolio in Review

As of Q2 2017, Boston Research & Management held 97 positions worth $185M, up 0.7% from $184M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q2 2017: portfolio turnover was 3.1%. Boston Research & Management opened 1 new position and exited 2, leaving the 97-position portfolio largely intact.

By sector, the portfolio is most concentrated in Industrials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Financials.

  • Boston Research & Management's largest Q2 2017 buy was Amgen: 1,180 shares worth $203K.
  • Boston Research & Management added most to The Mosaic Company in Q2 2017, an estimated $114K increase.
  • Boston Research & Management's biggest Q2 2017 reduction was Deere & Co, cutting an estimated $175K.
  • Boston Research & Management fully exited Howmet Aerospace in Q2 2017, selling an estimated $1.88M.
  • Boston Research & Management's ten largest holdings make up 23% of its $185M portfolio in Q2 2017.
  • Boston Research & Management opened 1 new position and closed 2 in Q2 2017.
  • Boston Research & Management's portfolio value rose 0.7% quarter-over-quarter to $185M.

Based on Boston Research & Management's 13F filing for Q2 2017, filed 8 Aug 2017.